In the letter by McCann entitled “Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML,” which appeared in the February 1, 2003, issue of Blood(Volume 101:1200), 3 coauthors were omitted: Kathy Gately, Eibhlin Conneally, and Mark Lawler.